On March 19, 2024, Nektar Therapeutics closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | -8.55% |
|
-6.14% | +89.38% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+89.38% | 20Cr | |
+55.19% | 81TCr | |
+45.42% | 65TCr | |
-6.09% | 35TCr | |
+21.92% | 34TCr | |
+10.18% | 30TCr | |
+18.18% | 25TCr | |
+2.25% | 23TCr | |
+13.17% | 22TCr | |
+10.86% | 17TCr |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Nektar Therapeutics announced that it has received $30 million in funding from TCG Crossover Management, LLC